TradingView
RocketTickers
2020年5月11日下午5點27分

Myriad Receives FDA Approval of myChoice CDx® as Companion Diagn 看多

NASDAQ:MYGN1D
Myriad Genetics, Inc.NASDAQ

描述

⋅
MYGN: Myriad Genetics, Inc.
2020-05-11 07:05:10
Myriad Receives FDA Approval of myChoice CDx® as Companion Diagnostic for Lynparza™ (olaparib) In Patients with Advanced Ovarian Cancer
Beyond Technical Analysis
更多